Anhui Huaren Health Pharmaceutical Co Ltd - Class A

SZSE:301408 (China)   Class A
Â¥ 12.27 (-1.92%) May 28
37.64
P/B:
2.46
Market Cap:
Â¥ 4.91B ($ 677.73M)
Enterprise V:
Â¥ 4.95B ($ 683.02M)
Volume:
1.57M
Avg Vol (2M):
2.49M
Volume:
1.57M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Anhui Huaren Health Pharmaceutical Co Ltd ( ) from 2023 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Anhui Huaren Health Pharmaceutical stock (SZSE:301408) PE ratio as of May 28 2024 is 37.64. More Details

Anhui Huaren Health Pharmaceutical Co Ltd (SZSE:301408) PE Ratio (TTM) Chart

To

Anhui Huaren Health Pharmaceutical Co Ltd (SZSE:301408) PE Ratio (TTM) Historical Data

Total 302
  • 1
  • 2
  • 3
  • 4
Anhui Huaren Health Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-28 37.6 2024-03-20 45.6
2024-05-28 37.6 2024-03-19 44.6
2024-05-27 38.4 2024-03-18 44.8
2024-05-24 38.7 2024-03-15 43.8
2024-05-23 38.8 2024-03-14 43.5
2024-05-22 39.4 2024-03-13 43.5
2024-05-21 38.9 2024-03-12 44.0
2024-05-20 39.3 2024-03-11 43.0
2024-05-17 39.2 2024-03-08 42.6
2024-05-16 38.9 2024-03-07 41.7
2024-05-15 38.2 2024-03-06 42.5
2024-05-14 39.1 2024-03-05 42.4
2024-05-13 39.2 2024-03-04 43.8
2024-05-10 38.8 2024-03-01 43.2
2024-05-09 39.7 2024-02-29 42.7
2024-05-08 39.1 2024-02-28 41.9
2024-05-07 39.3 2024-02-27 45.0
2024-05-06 39.0 2024-02-26 43.9
2024-04-30 38.4 2024-02-23 43.0
2024-04-29 37.3 2024-02-22 42.5
2024-04-26 34.6 2024-02-21 41.5
2024-04-25 34.6 2024-02-20 41.3
2024-04-24 34.3 2024-02-19 39.5
2024-04-23 33.7 2024-02-08 38.5
2024-04-22 33.3 2024-02-07 36.0
2024-04-19 33.0 2024-02-06 38.3
2024-04-18 33.5 2024-02-05 36.4
2024-04-17 34.0 2024-02-02 40.9
2024-04-16 31.3 2024-02-01 43.1
2024-04-15 33.9 2024-01-31 43.6
2024-04-12 35.1 2024-01-30 46.9
2024-04-11 36.0 2024-01-29 49.0
2024-04-10 35.9 2024-01-26 50.5
2024-04-09 37.1 2024-01-25 51.0
2024-04-08 35.9 2024-01-24 50.4
2024-04-03 37.4 2024-01-23 47.0
2024-04-02 38.3 2024-01-22 47.0
2024-04-01 37.7 2024-01-19 50.5
2024-03-29 36.7 2024-01-18 50.1
2024-03-28 36.4 2024-01-17 51.5
2024-03-27 40.5 2024-01-16 53.1
2024-03-26 41.1 2024-01-15 53.1
2024-03-25 41.6 2024-01-12 53.1
2024-03-22 43.2 2024-01-11 53.9
2024-03-21 44.8 2024-01-10 53.3

Anhui Huaren Health Pharmaceutical Co Ltd (SZSE:301408) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Anhui Huaren Health Pharmaceutical Co Ltd focuses on the pharmaceutical retail industry and forms a retail chain, retail centralized procurement, retail service, and retail e-commerce system.